Skip to main content
Premium Trial:

Request an Annual Quote

Ambry Becomes CSP for Roche NimbleGen Offerings

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ambry Genetics has been named a certified service provider for several product offerings from Roche NimbleGen.

Aliso Viejo, Calif.-based Ambry will offer services using Nimblegen's comparative genomic hybridization, chromatin immunoprecipitation-on-chip, DNA methylation, and gene expression tools. The addition of these applications means that Ambry is now certified on all Roche NimbleGen applications, Roche said today.

Ambry will conduct copy number variation, DNA methylation analysis, gene expression analysis, and DNA-protein interactions and chromatin structure analysis using the NimbleGen products at its lab in California.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.